Table 3.
Main outcome of ECMO patients
| Study (author and year) | Veno venous ECMO | Duration on ECMO (days) |
Patient endpoint (weaned/death) (total=136) |
Mortality from ECMO |
|---|---|---|---|---|
| Zhou et al. (2020) [17] | 100% | 10 (5-16) | 5 | 0 (0%) |
| Zhang et al. (2020) [18] | 100% | N/A | 5 | 3 (60%) |
| Takeda et al. (2020) [19] | 100% | N/A | 16 | 0 (0%) |
| Jacobs et al. (2020) [20] | 100% | N/A | 50 | 21 (42%) |
| Yang et al. (2020) [21] | 100% | N/A | 5 | 5 (100%) |
| Ruan et al. (2020) [22] | 100% | N/A | 7 | 7 (100%) |
| Li et al. (2020) [23] | 100% | 37 (9-47) | 6 | 3 (50%) |
| Guan et al. (2020) [24] | 100% | N/A | 5 | 5 (100%) |
| Zeng et al. (2020) [25] | 100% | 11 (3-28) | 8 | 5 (63%) |
| Beyls et al. (2020) [26] | 100% | 16 (2-28) | 16 | 4 (25%) |
| Osho et al. (2020) [27] | 100% | 12 (4-18) | 6 | 2 (33%) |
| Haye et al. (2020) [28] | 100% | 14 (8-28) | 7 | 2 (29%) |